Differentiating FSO and FSP approaches can better align definitions of models for CROs and sponsors.
Dr. Joachim Luithle
Advertisement
SVP, Head of Clinical Development Operations, Bayer
Articles by Dr. Joachim Luithle
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Why Patient Input Comes in Too Late—and What Earlier Engagement Changes
2
Recruitment in the Age of AI: Q&A with John Worden, Javara
3
What It Actually Means to Embed the Patient Voice in Trial Design
4
The Execution Gap: Why Clinical Trial Infrastructure Has to Be Built Before AI Can Deliver
5